Resistant cancer phenotype is a key obstacle in the successful therapy of prostate cancer. The primary aim of our study was to explore resistance mechanisms in the advanced type of prostate cancer cells (PC-3) and to clarify the role of autophagy in these processes. We performed time-lapse experiment (48 hours) with ROS generating plumbagin by using multimodal holographic microscope. Furthermore, we also performed the flow-cytometric analysis and the qRT-PCR gene expression analysis at 12 selected time points. TEM and confocal microscopy were used to verify the results. We found out that autophagy (namely mitophagy) is an important resistance mechanism. The major ROS producing mitochondria were coated by an autophagic membrane derived from endoplasmic reticulum and degraded. According to our results, increasing ROS resistance may be also accompanied by increased average cell size and polyploidization, which seems to be key resistance mechanism when connected with an escape from senescence. Many different types of cell-cell interactions were recorded including entosis, vesicular transfer, eating of dead or dying cells, and engulfment and cannibalism of living cells. Entosis was disclosed as a possible mechanism of polyploidization and enabled the long-term survival of cancer cells. Significantly reduced cell motility was found after the plumbagin treatment. We also found an extensive induction of pluripotency genes expression (NANOG, SOX2, and POU5F1) at the time-point of 20 hours. We suppose, that overexpression of pluripotency genes in the portion of prostate tumour cell population exposed to ROS leads to higher developmental plasticity and capability to faster respond to changes in the extracellular environment that could ultimately lead to an alteration of cell fate.

Central European Institute of Technology Brno University of Technology Technicka 3058 10 CZ 616 00 Brno Czech Republic

Department of Chemistry and Biochemistry Mendel University in Brno Zemedelska 1 CZ 613 00 Brno Czech Republic

Department of Pathological Physiology Faculty of Medicine Masaryk University Kamenice 5 CZ 625 00 Brno Czech Republic

Department of Physiology Faculty of Medicine Masaryk University Kamenice 5 CZ 625 00 Brno Czech Republic

TESCAN Brno s r o Brno Czech Republic

Zobrazit více v PubMed

Carroll AG, Voeller HJ, Sugars L, Gelmann EP. P53 oncogene mutations in 3 human prostate-cancer cell-lines. Prostate 1993; 23: 123–34. PubMed

Rubin SJ, Hallahan DE, Ashman CR, Brachman DG, Beckett MA, Virudachalam S, et al. 2 prostate carcinoma cell-lines demonstrate abnormalities in tumor suppressor genes. Journal of Surgical Oncology 1991; 46: 31–6. PubMed

Gustin JA, Maehama T, Dixon JE, Donner DB. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. Journal of Biological Chemistry 2001; 276: 27740–4. PubMed

Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Gronberg H, et al. The mutational landscape of prostate cancer. Eur Urol 2013; 64: 567–76. 10.1016/j.eururo.2013.05.029 PubMed DOI PMC

Bertram J, Peacock JW, Fazli L, Mui AL, Chung SW, Cox ME, et al. Loss of PTEN is associated with progression to androgen independence. Prostate 2006; 66: 895–902. PubMed

Wu Z, Conaway M, Gioeli D, Weber MJ, Theodorescu D. Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells. Prostate 2006; 66: 1114–23. PubMed

Choucair K, Ejdelman J, Brimo F, Aprikian A, Chevalier S, Lapointe J. PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity. Bmc Cancer 2012; 12. PubMed PMC

Gumulec J, Balvan J, Sztalmachova M, Raudenska M, Dvorakova V, Knopfova L, et al. Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle. International Journal of Oncology 2014; 44: 923–33. 10.3892/ijo.2013.2223 PubMed DOI

Sedletska Y, Giraud-Panis MJ, Malinge JM. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticancer Agents 2005; 5: 251–65. PubMed

Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramalingam SS, et al. Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions. Plos One 2013; 8. PubMed PMC

Powolny AA, Singh SV. Plumbagin-induced Apoptosis in Human Prostate Cancer Cells is Associated with Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species. Pharmaceutical Research 2008; 25: 2171–80. 10.1007/s11095-008-9533-3 PubMed DOI

Castro FAV, Mariani D, Panek AD, Eleutherio ECA, Pereira MD. Cytotoxicity Mechanism of Two Naphthoquinones (Menadione and Plumbagin) in Saccharomyces cerevisiae. Plos One 2008; 3. PubMed PMC

Sandur SK, Ichikawa H, Sethi G, Ahn KS, Aggarwal BB. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 2006; 281: 17023–33. PubMed

Qian W, Nishikawa M, Haque AM, Hirose M, Mashimo M, Sato E, et al. Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death. American Journal of Physiology-Cell Physiology 2005; 289: C1466–C75. PubMed

Panov A, Orynbayeva Z. Bioenergetic and Antiapoptotic Properties of Mitochondria from Cultured Human Prostate Cancer Cell Lines PC-3, DU145 and LNCaP. Plos One 2013; 8. PubMed PMC

Balvan J, Krizova A, Gumulec J, Raudenska M, Zbysek S, Sedlackova M, et al. Multimodal holographic microscopy: distinction between apoptosis and oncosis. Plos One 2015; 10: e0121674 10.1371/journal.pone.0121674 PubMed DOI PMC

Erenpreisa J, Cragg MS. Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal. Cancer Cell International 2013; 13. PubMed PMC

Trump BF, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: Oncosis, apoptosis, and necrosis. Toxicologic Pathology 1997; 25: 82–8. PubMed

Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature 2009; 458: 1131–5. 10.1038/nature07976 PubMed DOI PMC

Kroemer G, Perfettini J-L. Entosis, a key player in cancer cell competition. Cell Research 2014; 24: 1280–1. 10.1038/cr.2014.133 PubMed DOI PMC

Krajcovic M, Krishna S, Akkari L, Joyce JA, Overholtzer M. mTOR regulates phagosome and entotic vacuole fission. Molecular Biology of the Cell 2013; 24: 3736–45. 10.1091/mbc.E13-07-0408 PubMed DOI PMC

Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen GH, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10: 51–64. PubMed PMC

Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes & Development 2007; 21: 1367–81. PubMed PMC

Kimmelman AC. The dynamic nature of autophagy in cancer. Genes & Development 2011; 25: 1999–2010. PubMed PMC

Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 2014; 33: 116–28. 10.1038/onc.2013.96 PubMed DOI PMC

Menendez JA, Vellon L, Oliveras-Ferraros C, Cufi S, Vazquez-Martin A. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 2011; 10: 3658–77. 10.4161/cc.10.21.18128 PubMed DOI

Kolman P, Chmelik R. Coherence-controlled holographic microscope. Optics Express 2010; 18: 21990–2003. 10.1364/OE.18.021990 PubMed DOI

Slaby T, Kolman P, Dostal Z, Antos M, Lost'ak M, Chmelik R. Off-axis setup taking full advantage of incoherent illumination in coherence-controlled holographic microscope. Optics Express 2013; 21: 14747–62. 10.1364/OE.21.014747 PubMed DOI

Davies HG, Wilkins MHF. Interference microscopy and mass determination. Nature 1952; 169: 541- PubMed

Barer R. Refractometry and interferometry of living cells. Journal of the Optical Society of America 1957; 47: 545–56. PubMed

Chan LL-Y, Shen D, Wilkinson AR, Patton W, Lai N, Chan E, et al. A novel image-based cytometry method for autophagy detection in living cells. Autophagy 2012; 8: 1371–82. 10.4161/auto.21028 PubMed DOI PMC

Udovich JA, Besselsen DG, Gmitro AF. Assessment of acridine orange and SYTO 16 for in vivo imaging of the peritoneal tissues in mice. Journal of Microscopy-Oxford 2009; 234: 124–9. PubMed PMC

Mancuso P, Calleri A, Bertolini F, Tacchetti C, Heymach JV, Shalinsky DR. Quantification of Circulating Endothelial Cells by Flow Cytometry Response. Clinical Cancer Research 2009; 15: 3640–1. 10.1158/1078-0432.CCR-09-0160 PubMed DOI

Ibrahim P, Whiteley AS, Barer MR. SYTO16 labelling and flow cytometry of Mycobacterium avium. Letters in Applied Microbiology 1997; 25: 437–41. PubMed

Wlodkowic D, Skommer J, Darzynkiewicz Z. Rapid quantification of cell viability and apoptosis in B-cell lymphoma cultures using cyanine SYTO probes. Methods Mol Biol 2011; 740: 81–9. 10.1007/978-1-61779-108-6_10 PubMed DOI PMC

Aitken RJ, Whiting S, De Iuliis GN, McClymont S, Mitchell LA, Baker MA. Electrophilic Aldehydes Generated by Sperm Metabolism Activate Mitochondrial Reactive Oxygen Species Generation and Apoptosis by Targeting Succinate Dehydrogenase. Journal of Biological Chemistry 2012; 287: 33048–60. PubMed PMC

Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013; 32: 5129–43. 10.1038/onc.2012.640 PubMed DOI

Boeckler S, Westermann B. Mitochondrial ER Contacts Are Crucial for Mitophagy in Yeast. Developmental Cell 2014; 28: 450–8. 10.1016/j.devcel.2014.01.012 PubMed DOI

Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death and Differentiation 2013; 20: 31–42. 10.1038/cdd.2012.81 PubMed DOI PMC

Ding W-X, Yin X-M. Mitophagy: mechanisms, pathophysiological roles, and analysis. Biological Chemistry 2012; 393: 547–64. 10.1515/hsz-2012-0119 PubMed DOI PMC

Youle RJ, van der Bliek AM. Mitochondrial Fission, Fusion, and Stress. Science 2012; 337: 1062–5. 10.1126/science.1219855 PubMed DOI PMC

Parganlija D, Klinkenberg M, Dominguez-Bautista J, Hetzel M, Gispert S, Chimi MA, et al. Loss of PINK1 Impairs Stress-Induced Autophagy and Cell Survival. Plos One 2014; 9. PubMed PMC

Liu L, Feng D, Chen G, Chen M, Zheng Q, Song P, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nature Cell Biology 2012; 14: 177–85. 10.1038/ncb2422 PubMed DOI

Tan AS, Baty JW, Dong L-F, Bezawork-Geleta A, Endaya B, Goodwin J, et al. Mitochondrial Genome Acquisition Restores Respiratory Function and Tumorigenic Potential of Cancer Cells without Mitochondrial DNA. Cell Metabolism 2015; 21: 81–94. 10.1016/j.cmet.2014.12.003 PubMed DOI

Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nature Reviews Molecular Cell Biology 2008; 9: 1004–10. 10.1038/nrm2529 PubMed DOI PMC

Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes & Development 2007; 21: 1621–35. PubMed PMC

Sun Q, Luo T, Ren Y, Florey O, Shirasawa S, Sasazuki T, et al. Competition between human cells by entosis. Cell Research 2014; 24: 1299–310. 10.1038/cr.2014.138 PubMed DOI PMC

Florey O, Kim SE, Sandoval CP, Haynes CM, Overholtzer M. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Nature Cell Biology 2011; 13: 1335–U118. 10.1038/ncb2363 PubMed DOI PMC

Krajcovic M, Johnson NB, Sun Q, Normand G, Hoover N, Yao E, et al. A non-genetic route to aneuploidy in human cancers. Nature Cell Biology 2011; 13: 324–U07. 10.1038/ncb2174 PubMed DOI PMC

Nakajima S, Kato H, Takahashi S, Johno H, Kitamura M. Inhibition of NF-kappa B by MG132 through ER stress-mediated induction of LAP and LIP. Febs Letters 2011; 585: 2249–54. 10.1016/j.febslet.2011.05.047 PubMed DOI

Li Y, Bevilacqua E, Chiribau CB, Majumder M, Wang CP, Croniger CM, et al. Differential control of the CCAAT/enhancer-binding protein beta (C/EBP beta) products liver-enriched transcriptional activating protein (LAP) and liver- enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress. Journal of Biological Chemistry 2008; 283: 22443–56. 10.1074/jbc.M801046200 PubMed DOI PMC

Lim LY, Vidnovic N, Ellisen LW, Leong CO. Mutant p53 mediates survival of breast cancer cells. British Journal of Cancer 2009; 101: 1606–12. 10.1038/sj.bjc.6605335 PubMed DOI PMC

Abreu M, Sealy L. Cells Expressing the C/EBPbeta Isoform, LIP, Engulf Their Neighbors. Plos One 2012; 7. PubMed PMC

Buchheit CL, Weigel KJ, Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer 2014; 14: 632–41. 10.1038/nrc3789 PubMed DOI

Howe EN, Cochrane DR, Cittelly DM, Richer JK. miR-200c Targets a NF-kappa B Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer. Plos One 2012; 7. PubMed PMC

Loh YH, Wu Q, Chew JL, Vega VB, Zhang WW, Chen X, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics 2006; 38: 431–40. PubMed

Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917–20. PubMed

Ling G-Q, Chen D-B, Wang B-Q, Zhang L-S. Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines. Oncology Letters 2012; 4: 1264–8. PubMed PMC

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–76. PubMed

Park IH, Zhao R, West JA, Yabuuchi A, Huo HG, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141–U1. PubMed

Kohsaka S, Sasai K, Takahashi K, Akagi T, Tanino M, Kimura T, et al. A population of BJ fibroblasts escaped from Ras-induced senescence susceptible to transformation. Biochemical and Biophysical Research Communications 2011; 410: 878–84. 10.1016/j.bbrc.2011.06.082 PubMed DOI

Silva J, Chambers I, Pollard S, Smith A. Nanog promotes transfer of pluripotency after cell fusion. Nature 2006; 441: 997–1001. PubMed

Saunders A, Faiola F, Wang JL. Concise Review: Pursuing Self-Renewal and Pluripotency with the Stem Cell Factor Nanog. Stem Cells 2013; 31: 1227–36. 10.1002/stem.1384 PubMed DOI PMC

Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008; 2: 151–9. 10.1016/j.stem.2008.01.004 PubMed DOI PMC

Salmina K, Jankevics E, Huna A, Perminov D, Radovica I, Klymenko T, et al. Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cells. Experimental Cell Research 2010; 316: 2099–112. 10.1016/j.yexcr.2010.04.030 PubMed DOI

Mitchell R, Szabo E, Shapovalova Z, Aslostovar L, Makondo K, Bhatia M. Molecular Evidence for OCT4-Induced Plasticity in Adult Human Fibroblasts Required for Direct Cell Fate Conversion to Lineage Specific Progenitors. Stem Cells 2014; 32: 2178–87. 10.1002/stem.1721 PubMed DOI

Zhang S, Mercado-Uribe I, Liu J. Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel. International Journal of Cancer 2014; 134: 508–18. PubMed PMC

Roca H, Varsos Z, Pienta KJ. CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation. Journal of Biological Chemistry 2008; 283: 25057–73. 10.1074/jbc.M801073200 PubMed DOI PMC

Roca H, Varsos ZS, Mizutani K, Pienta KJ. CCL2, survivin and autophagy—New links with implications in human cancer. Autophagy 2008; 4: 969–71. PubMed

Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes & Development 2010; 24: 2239–63. PubMed PMC

Mali P, Ye ZH, Hommond HH, Yu XB, Lin J, Chen GB, et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 2008; 26: 1998–2005. 10.1634/stemcells.2008-0346 PubMed DOI

Zhang H, Chi Y, Gao K, Zhang X, Yao J. p53 Protein-mediated Up-regulation of MAP Kinase Phosphatase 3 (MKP-3) Contributes to the Establishment of the Cellular Senescent Phenotype through Dephosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2). Journal of Biological Chemistry 2015; 290: 1129–40. 10.1074/jbc.M114.590943 PubMed DOI PMC

Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. Embo Journal 2003; 22: 4212–22. PubMed PMC

Zemskova M, Lilly MB, Lin Y-W, Song JH, Kraft AS. p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase. Molecular Cancer Research 2010; 8: 1126–41. 10.1158/1541-7786.MCR-10-0174 PubMed DOI PMC

Zhang L, Ding P, Lv H, Zhang D, Liu G, Yang Z, et al. Number of Polyploid Giant Cancer Cells and Expression of EZH2 Are Associated with VM Formation and Tumor Grade in Human Ovarian Tumor. Biomed Research International 2014. PubMed PMC

Liu Y-q, Ji Y, Li X-z, Tian K-l, Young CYF, Lou H-x, et al. Retigeric acid B-induced mitophagy by oxidative stress attenuates cell death against prostate cancer cells in vitro. Acta Pharmacologica Sinica 2013; 34: 1183–91. 10.1038/aps.2013.68 PubMed DOI PMC

Basu HS, Schrieber CL, Sperger JM, Naundorf M, Weichman AM, Mehraein-Ghomi F, et al. Abstract 2899: Mitophagy imparts enzalutamide resistance in prostate cancer. Cancer Research 2015; 75: 2899.

Zhang HF, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. Journal of Biological Chemistry 2008; 283: 10892–903. 10.1074/jbc.M800102200 PubMed DOI PMC

Addressing cancer invasion and cell motility with quantitative light microscopy

Quantitative phase imaging unravels new insight into dynamics of mesenchymal and amoeboid cancer cell invasion

Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy